Dr. Li Zigang, graduated from the University of Science and Technology of China with a bachelor's degree in 2001, received his PhD in Chemistry from the University of Chicago in 2008, and a postdoctoral fellow in the Department of Chemistry and Chemical Biology at Harvard University in 2010. He returned to China in 2010 and was awarded the title of Peking University's "Hundred Talents Program" Special Researcher. He is currently a Ph.D. supervisor and project leader of the Department of Chemical Genomics at Peking University. The research team is committed to solving biological problems with chemical methods in the cross field of chemistry and biology. The research areas include peptide engineering and microbiological research, including the construction of methods for stabilizing the secondary structure of peptides, the research of peptide drugs for important human diseases, and antiviral peptides. Research and development. In recent years, in Science Advances, Nature Chemical Biology, Cell Chemical Biology, Proc. Natl. Acad. Sci., J. Am. Chem. Soc., Angew. Chem. Int. Ed . "," J. Med. Chem. "," Chemical Science "," Cancer research "," Chemical Reviews "and other international top academic journals published more than 80 papers, research results have been included in the cover of high-level magazines many times, and received The international and domestic counterparts have paid close attention to the international cooperation with Pfizer Pharmaceuticals, Bayer Healthcare, Roche China and other multinational pharmaceutical companies.
- About UsBrief IntroductionOpening Remarks for 2020Organization and Structure
- Research & DevelopmentFieldsGroupsSkills&Platforms
- LaboratoryChemical SynthesisPeptide Drug Development CenterHerb & Natural Plant ExtractPreparation & FormulationQuality Analysis Center
- News and EventsAcademic SpotlightsIndustry and BusinessConferences Agenda